The Tdap vaccine is safe for the vast majority of people who receive it, and serious side effects are rare. It protects against three bacterial diseases: tetanus, diphtheria, and pertussis (whooping cough). Most people who get it notice only mild reactions — a sore arm, some fatigue, maybe a low-grade fever that clears within a day or two.
This vaccine has been used in the United States since 2005. It replaced an older version that did not include a pertussis component for adolescents and adults. The Tdap shot is recommended for children around age 11 or 12, for adults who have never received it, and for pregnant women during each pregnancy.
Understanding what the evidence actually shows about side effects helps people make informed decisions. Here is what is well established, what is less certain, and what the research does not support.
What Is the Tdap Vaccine and Who Should Get It?
Tdap is a combination vaccine. The letters stand for tetanus, diphtheria, and acellular pertussis. The “ap” refers to acellular pertussis, meaning the pertussis component uses purified pieces of the bacterium rather than the whole killed organism.
The vaccine works by introducing inactivated toxins and surface proteins from these bacteria. The immune system recognizes them as foreign and builds antibodies. If a person later encounters the real bacteria, those antibodies help fight the infection before it causes serious illness.
The Centers for Disease Control and Prevention recommends Tdap for:
- Children at age 11 or 12, preferably in the preteen years
- Adults who have never received a Tdap dose
- Pregnant women during each pregnancy, ideally between 27 and 36 weeks
- Adolescents and adults who need a tetanus booster and have not had Tdap
After the initial Tdap dose, a Td or Tdap booster is recommended every 10 years. The tetanus and diphtheria components need periodic boosting because immunity from those parts of the vaccine fades over time.
Pertussis immunity fades faster — within a few years — which is one reason whooping cough continues to circulate even in highly vaccinated populations. The vaccine reduces the risk of severe illness but does not fully prevent infection or transmission. This is an important limitation that public health officials have acknowledged for years.
Is The Tdap Vaccine Safe? What the Evidence Shows
The Tdap vaccine has undergone extensive safety monitoring. Clinical trials before approval and ongoing surveillance systems after approval have tracked millions of doses.
The most common side effects are local reactions at the injection site. These include pain, redness, and swelling where the shot was given. These reactions are typically mild and resolve within a few days without treatment.
Systemic reactions can include headache, fatigue, muscle aches, and low-grade fever. These are also generally mild and short-lived.
Serious adverse events — such as severe allergic reactions (anaphylaxis) — are rare. Anaphylaxis occurs in roughly one per million vaccine doses for most vaccines, according to established vaccine safety data. It is treatable when it occurs, which is why vaccine providers are equipped to manage allergic reactions.
One side effect that received attention in older tetanus vaccine formulations was brachial neuritis, a nerve inflammation causing pain and weakness in the arm or shoulder. This was more associated with older whole-cell or earlier formulations. The current Tdap formulation has a much lower reported rate, though it has not been zero. Some case reports exist, but the evidence does not establish a clear causal link at current rates.
What Are the Most Common Side Effects of Tdap?
Clinical trials and post-licensure surveillance consistently show a predictable pattern of side effects. Most people experience at least one, but they are typically mild.
Local reactions are the most frequent. Pain at the injection site is reported by a majority of recipients. Redness and swelling occur in a smaller but still substantial proportion. These reactions peak within the first day and improve steadily.
Systemic reactions are less common than local ones but still occur. These include:
- Headache
- Fatigue or feeling tired
- Muscle aches
- Low-grade fever (generally under 101°F)
- Nausea
These symptoms usually appear within the first day after vaccination and resolve within one to three days. They reflect the immune system responding to the vaccine, not an infection.
Swelling of the entire arm after vaccination has been reported, particularly after repeat doses of tetanus-containing vaccines. This is uncommon, generally self-limited, and does not typically prevent future vaccination. However, some clinicians may choose to monitor more closely or adjust timing for people who have had this reaction.
Are There Serious Risks Associated With Tdap?
Serious complications from Tdap are rare. The risk of a severe reaction is far lower than the risk of complications from the diseases the vaccine prevents.
Tetanus, for example, has a mortality rate that can approach 10% to 20% even with modern intensive care, according to established medical references. Diphtheria can cause heart failure and paralysis. Pertussis can be life-threatening in infants, who are too young to be fully vaccinated.
Guillain-Barré syndrome (GBS) has been reported after vaccination with tetanus-containing vaccines, including Tdap. The evidence for a causal relationship is not strong. Some studies have found a small increased risk, while others have not. The background rate of GBS in the general population is approximately 1 to 2 cases per 100,000 people per year. If vaccination increases that risk at all, the increase appears to be very small. This remains an area of ongoing monitoring.
Shoulder injury related to vaccine administration (SIRVA) is a recognized complication that can occur with any injected vaccine, not just Tdap. It results from the needle being placed too high on the arm, causing inflammation in the shoulder joint or bursa. Proper injection technique prevents this. When it does occur, it can cause prolonged pain and limited range of motion. It is not caused by the vaccine ingredients themselves.
There is no evidence that Tdap causes autism, autoimmune diseases, or infertility. These claims have been investigated and not supported by the evidence.
What About Tdap During Pregnancy?
Tdap is recommended during every pregnancy, typically between 27 and 36 weeks. The purpose is to protect the newborn before they can receive their own vaccines.
When a pregnant woman receives Tdap, her body produces antibodies that cross the placenta. These antibodies provide passive protection to the baby during the first months of life, when pertussis is most dangerous. Infants under 2 months old are at highest risk of severe complications and death from whooping cough.
Safety data on Tdap in pregnancy is substantial. Multiple studies and surveillance systems have not found an increased risk of miscarriage, stillbirth, preterm birth, or birth defects associated with Tdap vaccination during pregnancy. The evidence supporting this is strong and consistent.
Some pregnant women worry about receiving a vaccine while pregnant. The data here is reassuring, but it is important to distinguish between reassurance based on large studies and reassurance based on assumption. In this case, the reassurance comes from large studies and active monitoring systems.
How Does Tdap Compare to Other Vaccines?
Every vaccine has a side effect profile. Tdap’s profile is similar to other inactivated vaccines: local reactions are common, systemic reactions are less common, and serious reactions are rare.
The table below summarizes the general pattern. It is not a direct comparison of rates, which vary by vaccine and by study.
| Reaction Type | Tdap | Typical Inactivated Vaccines |
|---|---|---|
| Local pain, redness, swelling | Common | Common |
| Fatigue, headache, muscle aches | Less common | Less common |
| Fever | Uncommon | Uncommon |
| Severe allergic reaction | Rare | Rare |
One difference is that Tdap contains tetanus toxoid, which is associated with a higher rate of local reactions than some other vaccine components. This is well documented and is one reason why boosters are spaced 10 years apart rather than given more frequently.
What Should You Do If You Have a Reaction?
Most reactions after Tdap do not require medical attention. Over-the-counter pain relievers can help with arm soreness or headache. A cool compress on the injection site can reduce swelling.
You should seek medical care if you experience:
- Difficulty breathing or throat swelling
- Rapid heartbeat or dizziness
- Hives or rash over the body
- High fever (over 103°F) that does not improve
- Severe pain or weakness in the arm or shoulder that worsens over time
These symptoms are uncommon. When they occur, they should be evaluated promptly. If you have had a severe allergic reaction to any vaccine component in the past, you should not receive Tdap without consulting a doctor first.
Reporting side effects to the Vaccine Adverse Event Reporting System (VAERS) helps public health officials monitor safety. VAERS accepts reports from anyone, but a report does not prove the vaccine caused the problem. It is one tool among many used to detect potential safety signals.
What Does the Evidence Not Show?
Some claims about Tdap side effects are not supported by evidence. There is no established link between Tdap and autism, sudden infant death syndrome (SIDS), or infertility. These have been studied and the evidence does not support a causal relationship.
Some people report symptoms after vaccination that they attribute to the vaccine. This is understandable, but it does not establish causation. The timing of symptoms after any medical intervention can create a temporal association that is not causal.
This does not mean all reactions are imagined. Local and systemic reactions are real and expected. The point is that serious long-term harms have not been demonstrated in large studies.
It is also important to note that the evidence base for Tdap safety is large but not infinite. Rare events may not be detected even in large surveillance systems. This is true for all vaccines and all medical products. Ongoing monitoring exists precisely because rare events can emerge over time.
Frequently Asked Questions
Is Tdap vaccine safe for adults over 65?
Tdap is safe for adults over 65 and is recommended for those who have not received it. The same side effect profile applies, though some older adults may have milder local reactions.
Can Tdap cause long-term side effects?
Serious long-term side effects from Tdap are rare and have not been consistently demonstrated in large studies. Most side effects resolve within a few days.
How long do Tdap side effects last?
Most side effects last one to three days. Local reactions at the injection site may persist slightly longer but typically improve steadily after the first day.
Is it safe to get Tdap while pregnant?
Yes. Tdap is recommended during every pregnancy, usually between 27 and 36 weeks. Large studies have not found an increased risk of miscarriage, preterm birth, or birth defects.
